Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT4 receptor
Open Access
- 1 August 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 100 (4), 665-667
- https://doi.org/10.1111/j.1476-5381.1990.tb14073.x
Abstract
Intravenous bolus Injections of 5-hydroxytryptamine (5-HT; 3, 10 and 30 μg kg−1), 5-methoxytryptamine (5-MeO-T; 3, 10 and 30 μg kg−1), renzapride (BRL 24924; 3, 10, 30 and 100μgkg−1) and isoprenaline (0.03, 0.1 and 0.3 μg kg−1) to anaesthetized pigs increased heart rate by, respectively, 22 ± 3, 44 ± 3 and 65 ± 4 beats min−1 (5-HT; n = 17); 12 ± 1, 26 ± 2 and 44 ± 4 beats min−1 (5-MeO-T; n = 15), 5 ± 2, 11 ± 2, 18 ± 4 and 37 ± 5 beats min−1 (renzapride; n = 8) and 17 ± 2, 46 ± 3 and 75 ± 3 beats min−1 (isoprenaline; n = 13). The responses to 5-HT, 5-MeO-T and renzapride were antagonized by ICS 205–930 (1 and 3 mg kg−1, i.v.), which did not modify the increases in heart rate by isoprenaline. Renzapride showed tachyphylaxis and attenuated the responses to 5-HT. These findings indicate that 5-HT elicits tachycardia in the pig by acting on a novel receptor, either similar or identical to the 5-HT4 receptor identified in mouse brain colliculi.This publication has 7 references indexed in Scilit:
- Cardiovascular Effects of Serotonin Agonists and AntagonistsJournal of Cardiovascular Pharmacology, 1990
- The 5-HT4 receptor: naughty, but niceTrends in Pharmacological Sciences, 1989
- The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neuronsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- 5‐Hydroxytryptamine‐induced tachycardia in the pig: possible involvement of a new type of 5‐hydroxytryptamine receptorBritish Journal of Pharmacology, 1988
- A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930European Journal of Pharmacology, 1988
- Increased gut cholinergic activity and antagonism of 5‐hydroxytryptamine M‐receptors by BRL 24924: potential clinical importance of BRL 24924British Journal of Pharmacology, 1987